| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 02:45:42 UTC |
|---|
| Update Date | 2022-11-30 19:25:55 UTC |
|---|
| HMDB ID | HMDB0114804 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(14:1(9Z)/22:1(13Z)) |
|---|
| Description | PA(14:1(9Z)/22:1(13Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:1(9Z)/22:1(13Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of erucic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCC\C=C/CCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC InChI=1S/C39H73O8P/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-24-26-28-30-32-34-39(41)47-37(36-46-48(42,43)44)35-45-38(40)33-31-29-27-25-23-14-12-10-8-6-4-2/h10,12,16-17,37H,3-9,11,13-15,18-36H2,1-2H3,(H2,42,43,44)/b12-10-,17-16-/t37-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Myristoleoyl-2-erucoyl-sn-glycero-3-phosphate | HMDB | | 1-Myristoleoyl-2-erucoyl-sn-phosphatidic acid | HMDB | | PA(14:1/22:1) | HMDB | | PA(14:1N5/22:1N9) | HMDB | | PA(14:1W5/22:1W9) | HMDB | | PA(36:2) | HMDB | | Phosphatidic acid(14:1(9Z)/22:1(13Z)) | HMDB | | Phosphatidic acid(14:1/22:1) | HMDB | | Phosphatidic acid(14:1n5/22:1n9) | HMDB | | Phosphatidic acid(14:1W5/22:1W9) | HMDB | | Phosphatidic acid(36:2) | HMDB | | Phosphatidate(14:1(9Z)/22:1(13Z)) | HMDB | | Phosphatidate(14:1/22:1) | HMDB | | Phosphatidate(14:1N5/22:1N9) | HMDB | | Phosphatidate(14:1W5/22:1W9) | HMDB | | Phosphatidate(36:2) | HMDB | | [(2R)-2-[(13Z)-Docos-13-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonate | HMDB | | 1-myristoleoyl-2-erucoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-myristoleoyl-2-erucoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(14:1/22:1) | SMPDB, HMDB | | PA(14:1n5/22:1n9) | SMPDB, HMDB | | PA(14:1w5/22:1w9) | SMPDB, HMDB | | PA(36:2) | SMPDB, HMDB | | Phosphatidic acid(14:1(9Z)/22:1(13Z)) | SMPDB, HMDB | | Phosphatidic acid(14:1/22:1) | SMPDB, HMDB | | Phosphatidic acid(14:1n5/22:1n9) | SMPDB, HMDB | | Phosphatidic acid(14:1w5/22:1w9) | SMPDB, HMDB | | Phosphatidic acid(36:2) | SMPDB, HMDB | | Phosphatidate(14:1(9Z)/22:1(13Z)) | SMPDB, HMDB | | Phosphatidate(14:1/22:1) | SMPDB, HMDB | | Phosphatidate(14:1n5/22:1n9) | SMPDB, HMDB | | Phosphatidate(14:1w5/22:1w9) | SMPDB, HMDB | | PA(14:1(9Z)/22:1(13Z)) | SMPDB |
|
|---|
| Chemical Formula | C39H73O8P |
|---|
| Average Molecular Weight | 700.979 |
|---|
| Monoisotopic Molecular Weight | 700.504306309 |
|---|
| IUPAC Name | [(2R)-2-[(13Z)-docos-13-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-2-[(13Z)-docos-13-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCC\C=C/CCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC |
|---|
| InChI Identifier | InChI=1S/C39H73O8P/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-24-26-28-30-32-34-39(41)47-37(36-46-48(42,43)44)35-45-38(40)33-31-29-27-25-23-14-12-10-8-6-4-2/h10,12,16-17,37H,3-9,11,13-15,18-36H2,1-2H3,(H2,42,43,44)/b12-10-,17-16-/t37-/m1/s1 |
|---|
| InChI Key | VYZLRPSFDVOCPX-DFQIBMCCSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0064711)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0088720)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/22:2(13Z,16Z)) (PathBank: SMP0088721)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0088722)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/24:0) (PathBank: SMP0088726)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0073462)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/24:1(15Z)) (PathBank: SMP0073464)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0088724)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/14:1(9Z)) (PathBank: SMP0020899)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/16:1(9Z)) (PathBank: SMP0020900)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/18:1(11Z)) (PathBank: SMP0020901)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/18:1(9Z)) (PathBank: SMP0020902)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/20:1(11Z)) (PathBank: SMP0020903)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0020904)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/18:2(9Z,12Z)) (PathBank: SMP0020907)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0020908)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0020909)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0020913)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0020914)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0020915)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0020916)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/20:2(11Z,14Z)) (PathBank: SMP0032605)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/22:1(13Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0032606)
- Cardiolipin Biosynthesis CL(14:1(9Z)/22:1(13Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0097663)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 9.14 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 34.1109 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.95 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5061.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 521.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 351.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 239.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1053.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1742.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1299.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 257.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3484.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1101.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2755.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1303.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 710.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 590.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 820.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(14:1(9Z)/22:1(13Z)),1TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC | 4936.9 | Semi standard non polar | 33892256 | | PA(14:1(9Z)/22:1(13Z)),1TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC | 4354.1 | Standard non polar | 33892256 | | PA(14:1(9Z)/22:1(13Z)),1TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC | 5666.2 | Standard polar | 33892256 | | PA(14:1(9Z)/22:1(13Z)),2TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC | 4869.4 | Semi standard non polar | 33892256 | | PA(14:1(9Z)/22:1(13Z)),2TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC | 4330.8 | Standard non polar | 33892256 | | PA(14:1(9Z)/22:1(13Z)),2TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC | 4886.3 | Standard polar | 33892256 | | PA(14:1(9Z)/22:1(13Z)),1TBDMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC | 5174.3 | Semi standard non polar | 33892256 | | PA(14:1(9Z)/22:1(13Z)),1TBDMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC | 4450.0 | Standard non polar | 33892256 | | PA(14:1(9Z)/22:1(13Z)),1TBDMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC | 5653.2 | Standard polar | 33892256 |
|
|---|